Exact Mass: 309.2456

Exact Mass Matches: 309.2456

Found 138 metabolites which its exact mass value is equals to given mass value 309.2456, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Methadone

GlaxoSmithKline brand OF methadone hydrochloride

C21H27NO (309.2093)


A synthetic opioid that is used as the hydrochloride. It is an opioid analgesic that is primarily a mu-opioid agonist. It has actions and uses similar to those of morphine. It also has a depressant action on the cough center and may be given to control intractable cough associated with terminal lung cancer. Methadone is also used as part of the treatment of dependence on opioid drugs, although prolonged use of methadone itself may result in dependence. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1082-3) CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8112; ORIGINAL_PRECURSOR_SCAN_NO 8110 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8059; ORIGINAL_PRECURSOR_SCAN_NO 8057 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8114; ORIGINAL_PRECURSOR_SCAN_NO 8112 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8021; ORIGINAL_PRECURSOR_SCAN_NO 8016 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8067; ORIGINAL_PRECURSOR_SCAN_NO 8064 CONFIDENCE standard compound; INTERNAL_ID 513; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8100; ORIGINAL_PRECURSOR_SCAN_NO 8098 N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics CONFIDENCE standard compound; EAWAG_UCHEM_ID 2828 CONFIDENCE standard compound; INTERNAL_ID 1628

   

Dicyclomine

2-(Diethylamino)ethyl 1-cyclohexylcyclohexanecarboxylic acid

C19H35NO2 (309.2668)


Dicyclomine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used as an antispasmodic and in urinary incontinence. It has little effect on glandular secretion or the cardiovascular system. It does have some local anesthetic properties and is used in gastrointestinal, biliary, and urinary tract spasms. [PubChem]Action is achieved via a dual mechanism: (1) a specific anticholinergic effect (antimuscarinic) at the acetylcholine-receptor sites and (2) a direct effect upon smooth muscle (musculotropic). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Diphenidol

SmithKline beecham brand OF diphenidol hydrochloride

C21H27NO (309.2093)


Diphenidol is only found in individuals that have used or taken this drug. It is an antiemetic agent used in the treatment of vomiting and vertigo. Diphenidol overdose may result in serious toxicity in children.The mechanism by which diphenidol exerts its antiemetic and antivertigo effects is not precisely known. It is thought to diminish vestibular stimulation and depress labyrinthine function and as an antimuscarinic agent. An action on the medullary chemoreceptive trigger zone may also be involved in the antiemetic effect. Diphenidol has no significant sedative, tranquilizing, or antihistaminic action. It has a weak peripheral anticholinergic effect. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

Palustrine

(13S,17S)-17-[(1S)-1-hydroxypropyl]-1,5,10-triazabicyclo[11.4.0]heptadec-14-en-11-one

C17H31N3O2 (309.2416)


   

3-(Diphenylmethoxymethyl)-1-ethylpiperidine hydrochloride

3-(Diphenylmethoxymethyl)-1-ethylpiperidine hydrochloride

C21H27NO (309.2093)


   

Palustrine

13-(1-hydroxypropyl)-1H,2H,3H,4H,5H,6H,7H,8H,9H,10H,11H,13H,14H,16aH-pyrido[2,1-d]1,5,9-triazacyclotridecan-2-one

C17H31N3O2 (309.2416)


   

(9Z,11E,14Z)-(13S)-hydroperoxyoctadeca-(9,11,14)-trienoate

(9Z,11E,14Z)-(13S)-Hydroperoxyoctadeca-(9,11,14)-trienoic acid

C18H29O4 (309.2066)


(9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate can be found in a number of food items such as wasabi, european chestnut, savoy cabbage, and prunus (cherry, plum), which makes (9z,11e,14z)-(13s)-hydroperoxyoctadeca-(9,11,14)-trienoate a potential biomarker for the consumption of these food products.

   

Holaromine

Holaromine

C22H31N (309.2456)


   
   
   

CJ 13217

(E)-2-(3,7-Dimethyl-2,6-octadienyl)-1,3-dimethyl-4(1H)-quinolinone

C21H27NO (309.2093)


   
   
   
   

Benproperine

Benproperine

C21H27NO (309.2093)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent CONFIDENCE standard compound; EAWAG_UCHEM_ID 3296

   

XLR11 N-(4-pentenyl) analog

XLR11 N-(4-pentenyl) analog

C21H27NO (309.2093)


   

Dihydoroferuloyl Octylamine

Dihydoroferuloyl Octylamine

C18H31NO3 (309.2304)


Annotation level-3

   

(16aR)-13t-((S)-1-Hydroxy-propyl)-(16ar)-1,4,5,6,7,8,9,10,11,13,16,16a-dodecahydro-3H-pyrido[2,1-d][1,5,9]triazacyclotridecin-2-on|4-(1-hydroxy-propyl)-1,4,6,7,8,9,10,11,12,13,15,15a-dodecahydro-5H-4a,8,13-triaza-benzocyclotridecen-14-one|Palustrin|Palustrine

(16aR)-13t-((S)-1-Hydroxy-propyl)-(16ar)-1,4,5,6,7,8,9,10,11,13,16,16a-dodecahydro-3H-pyrido[2,1-d][1,5,9]triazacyclotridecin-2-on|4-(1-hydroxy-propyl)-1,4,6,7,8,9,10,11,12,13,15,15a-dodecahydro-5H-4a,8,13-triaza-benzocyclotridecen-14-one|Palustrin|Palustrine

C17H31N3O2 (309.2416)


   

Allopumiliotoxin 309D

Allopumiliotoxin 309D

C19H35NO2 (309.2668)


   

(-)-isopuloupone|isopuloupone

(-)-isopuloupone|isopuloupone

C21H27NO (309.2093)


   

Malarboreine

Malarboreine

C21H27NO (309.2093)


   
   

(+)-decaryine A

(+)-decaryine A

C17H31N3O2 (309.2416)


   

12-hydroxy-7-multijuguinol

12-hydroxy-7-multijuguinol

C18H31NO3 (309.2304)


   

1-methyl-2-[(1E,5Z)-1,5-undecadienyl]-4(1H)-quinolone

1-methyl-2-[(1E,5Z)-1,5-undecadienyl]-4(1H)-quinolone

C21H27NO (309.2093)


   

12-hydroxy-8-multijuguinol

12-hydroxy-8-multijuguinol

C18H31NO3 (309.2304)


   

N,3-Di-Ac-2-Amino-5,7-tetradecadien-3-ol

N,3-Di-Ac-2-Amino-5,7-tetradecadien-3-ol

C18H31NO3 (309.2304)


   

L-Isoleucyl-L-amiclenomycin

L-Isoleucyl-L-amiclenomycin

C16H27N3O3 (309.2052)


   

hydroxylanyuamide I

hydroxylanyuamide I

C18H31NO3 (309.2304)


   

2-amino-9-methyloctadeca-4,8,10-triene-1,3-diol

2-amino-9-methyloctadeca-4,8,10-triene-1,3-diol

C19H35NO2 (309.2668)


   

(+)-puloupone|Puloupone

(+)-puloupone|Puloupone

C21H27NO (309.2093)


   

N1,N10-ditigloylspermidine

N1,N10-ditigloylspermidine

C17H31N3O2 (309.2416)


   

pseudopteroxazole

pseudopteroxazole

C21H27NO (309.2093)


A natural product found in Pseudopterogorgia elisabethae.

   

N-cis-tetradec-9Z-enoyl-L-Homoserine lactone

N-cis-tetradec-9Z-enoyl-L-Homoserine lactone

C18H31NO3 (309.2304)


   
   

methadone

methadone

C21H27NO (309.2093)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   
   

Macusine B

Macusine B

[C20H25N2O]+ (309.1967)


Origin: Plant; SubCategory_DNP: Monoterpenoid indole alkaloids, Bisindole alkaloids, Indole alkaloids

   

(8S,Z)-6-((2R)-6-hydroxy-2,5-dimethyloctylidene)-8-methyloctahydroindolizin-8-ol

(8S,Z)-6-((2R)-6-hydroxy-2,5-dimethyloctylidene)-8-methyloctahydroindolizin-8-ol

C19H35NO2 (309.2668)


   

(7R,8R,E)-6-((2R)-2,5-dimethyloctylidene)-8-methyloctahydroindolizine-7,8-diol

(7R,8R,E)-6-((2R)-2,5-dimethyloctylidene)-8-methyloctahydroindolizine-7,8-diol

C19H35NO2 (309.2668)


   

(7R)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)octane-2,3-diol

(7R)-4,7-dimethyl-8-((8R,Z)-8-methylhexahydroindolizin-6(5H)-ylidene)octane-2,3-diol

C19H35NO2 (309.2668)


   

(1S,Z)-3-((2R)-5-hydroxy-2,4-dimethylheptylidene)-1-methyloctahydro-2H-quinolizin-1-ol

(1S,Z)-3-((2R)-5-hydroxy-2,4-dimethylheptylidene)-1-methyloctahydro-2H-quinolizin-1-ol

C19H35NO2 (309.2668)


   

9-methyl-sphinga-4E,8E,10E-trienine

9-methyl-sphinga-4E,8E,10E-trienine

C19H35NO2 (309.2668)


   

C14:1-9-cis-(L)-HSL

(S,Z)-N-(2-oxotetrahydrofuran-3-yl)tetradec-9-enamide

C18H31NO3 (309.2304)


   

N-decanoyl histidine

N-decanoyl-histidine

C16H27N3O3 (309.2052)


   

N-(7Z-tetradecenoyl)-homoserine lactone

N-(7Z-tetradecenoyl)-homoserine lactone

C18H31NO3 (309.2304)


   

SPB 19:3;O2

9-methyl-sphinga-4E,8E,10E-trienine

C19H35NO2 (309.2668)


   

Isomethadone

6-(Dimethylamino)-5-methyl-4,4-diphenyl-3-hexanone

C21H27NO (309.2093)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

4-[trans-4-(trans-4-Propylcyclohexyl) cyclohexyl]benzonitrile

4-[trans-4-(trans-4-Propylcyclohexyl) cyclohexyl]benzonitrile

C22H31N (309.2456)


   

N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester

N-Boc-1,2,5,6-tetrahydropyridine-4-boronic acid pinacol ester

C16H28BNO4 (309.2111)


   

2-(N-Propyl-N-phenethylamino)-5-hydroxytetralin

2-(N-Propyl-N-phenethylamino)-5-hydroxytetralin

C21H27NO (309.2093)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

N-(2,5-dimethylphenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

N-(2,5-dimethylphenyl)-2-[4-(2-methylpropyl)phenyl]propanamide

C21H27NO (309.2093)


   

N,N-DIMETHYL-N-[3-(SULFOOXY)PROPYL]-1-NONANAMINIUM HYDROXIDE, INNER SALT

N,N-DIMETHYL-N-[3-(SULFOOXY)PROPYL]-1-NONANAMINIUM HYDROXIDE, INNER SALT

C14H31NO4S (309.1974)


   

bis(2-hydroxyethyl)-3-aminopropyltriethoxysilane

bis(2-hydroxyethyl)-3-aminopropyltriethoxysilane

C13H31NO5Si (309.1971)


   

bis(3,5-dimethylphenyl)-[(2R)-pyrrolidin-2-yl]methanol

bis(3,5-dimethylphenyl)-[(2R)-pyrrolidin-2-yl]methanol

C21H27NO (309.2093)


   

Levomethadone

(6R)-6-(dimethylamino)-4,4-diphenylheptan-3-one

C21H27NO (309.2093)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

TERT-BUTYL 5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,6-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H28BNO4 (309.2111)


   

1-O-OCTYL-D17-β-D-GLUCOPYRANOSIDE

1-O-OCTYL-D17-β-D-GLUCOPYRANOSIDE

C14H11D17O6 (309.2953)


   

bis(3,5-dimethylphenyl)-[(2S)-pyrrolidin-2-yl]methanol

bis(3,5-dimethylphenyl)-[(2S)-pyrrolidin-2-yl]methanol

C21H27NO (309.2093)


   

5-(4-butylphenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

5-(4-butylphenyl)-N-cyclopentyl-2-methylpyrimidin-4-amine

C20H27N3 (309.2205)


   

9-[3-(dimethylamino)propyl]-10,10-dimethylanthracen-9-ol

9-[3-(dimethylamino)propyl]-10,10-dimethylanthracen-9-ol

C21H27NO (309.2093)


   

1-(4-butoxyphenyl)-N-(4-butylphenyl)methanimine

1-(4-butoxyphenyl)-N-(4-butylphenyl)methanimine

C21H27NO (309.2093)


   

TERT-BUTYL 6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

TERT-BUTYL 6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDROPYRIDINE-1(2H)-CARBOXYLATE

C16H28BNO4 (309.2111)


   

Dextromethadone

Dextromethadone

C21H27NO (309.2093)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Benproperine, (S)-

Benproperine, (S)-

C21H27NO (309.2093)


   

Benproperine, (R)-

Benproperine, (R)-

C21H27NO (309.2093)


   

(S,Z)-N-(2-oxotetrahydrofuran-3-yl)tetradec-9-enamide

(S,Z)-N-(2-oxotetrahydrofuran-3-yl)tetradec-9-enamide

C18H31NO3 (309.2304)


   

(19E)-4-methylsarpagan-4-ium-17-ol

(19E)-4-methylsarpagan-4-ium-17-ol

C20H25N2O+ (309.1967)


   

Gondoate

Gondoate

C20H37O2- (309.2793)


A very long-chain fatty acid anion that is the conjugate base of gondoic acid, formed by deprotonation of the carboxylic acid group.

   

(9Z,11E,13S,15Z)-13-Hydroperoxyoctadeca-9,11,15-trienoate

(9Z,11E,13S,15Z)-13-Hydroperoxyoctadeca-9,11,15-trienoate

C18H29O4- (309.2066)


Conjugate base of (9Z,11E,13S,15Z)-13-hydroperoxyoctadeca-9,11,15-trienoic acid.

   

(9S,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(9S,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2066)


   
   

(9R,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(9R,10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2066)


   

(8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate

(8E,10S,12Z,15Z)-10-hydroperoxyoctadec-8,12,15-trienoate

C18H29O4- (309.2066)


   

Gadoleate

Gadoleate

C20H37O2- (309.2793)


A unsaturated fatty acid anion that is the conjugate base of gadoleic acid, formed by deprotonation of the carboxylic acid group.

   

(9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate

(9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienoate

C18H29O4- (309.2066)


The conjugate base of (9Z,11E,13S,14Z)-13-hydroperoxyoctadeca-9,11,14-trienic acid.

   

(5Z)-icos-5-enoate

(5Z)-icos-5-enoate

C20H37O2- (309.2793)


   

13-gamma-Ketol

13-gamma-Ketol

C18H29O4- (309.2066)


   

13-alpha-Ketol

13-alpha-Ketol

C18H29O4- (309.2066)


   

9-gamma-Ketol (linolenic acid)

9-gamma-Ketol (linolenic acid)

C18H29O4- (309.2066)


   

9S-alpha-ketol (linolenic acid)

9S-alpha-ketol (linolenic acid)

C18H29O4- (309.2066)


   

9(R)-alpha-ketol (linolenic acid)

9(R)-alpha-ketol (linolenic acid)

C18H29O4- (309.2066)


   

(9E,11E,14E)-13-hydroperoxyoctadeca-9,11,14-trienoate

(9E,11E,14E)-13-hydroperoxyoctadeca-9,11,14-trienoate

C18H29O4- (309.2066)


   

Methadone-D9

Methadone-D9

C21H27NO (309.2093)


   

(9Z,11E,15Z)-13-hydroperoxyoctadecatrienoate

(9Z,11E,15Z)-13-hydroperoxyoctadecatrienoate

C18H29O4- (309.2066)


   

4-[2-(1-hexyl-2-pyridin-1-iumyl)ethenyl]-N,N-dimethylaniline

4-[2-(1-hexyl-2-pyridin-1-iumyl)ethenyl]-N,N-dimethylaniline

C21H29N2+ (309.2331)


   

(R)-2-hydroperoxy-alpha-linolenate

(R)-2-hydroperoxy-alpha-linolenate

C18H29O4- (309.2066)


A hydroperoxy fatty acid anion that is the conjugate base of (R)-2-hydroperoxy-alpha-linolenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

(10E,12Z,15Z)-9-hydroperoxyoctadeca-10,12,15-trienoate

C18H29O4- (309.2066)


   

10-HPO(6,8,12)TrE(1-)

10-HPO(6,8,12)TrE(1-)

C18H29O4- (309.2066)


A polyunsaturated fatty acid anion that is the conjugate base of 10-HPO(6,8,12)TrE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

10(R)-HPO(6,8,12)TrE(1-)

10(R)-HPO(6,8,12)TrE(1-)

C18H29O4- (309.2066)


A polyunsaturated fatty acid anion that is the conjugate base of 10(R)-HPO(6,8,12)TrE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

dihydro-ML-236C carboxylate

dihydro-ML-236C carboxylate

C18H29O4- (309.2066)


   

(9Z,11E,13R,15Z)-13-hydroperoxyoctadecatrienoate

(9Z,11E,13R,15Z)-13-hydroperoxyoctadecatrienoate

C18H29O4- (309.2066)


   

(9Z,11S,12Z,15Z)-11-hydroperoxyoctadecatrienoate

(9Z,11S,12Z,15Z)-11-hydroperoxyoctadecatrienoate

C18H29O4- (309.2066)


   

(9Z,11R,12Z,15Z)-11-hydroperoxyoctadecatrienoate

(9Z,11R,12Z,15Z)-11-hydroperoxyoctadecatrienoate

C18H29O4- (309.2066)


   

Gadelaidate

Gadelaidate

C20H37O2- (309.2793)


An unsaturated fatty acid anion that is the conjugate base of gadelaidic acid, arising from deprotonation of the carboxy group.

   

Plasmodiophorol A

Plasmodiophorol A

C18H29O4- (309.2066)


   

Plasmodiophorol B

Plasmodiophorol B

C18H29O4- (309.2066)


   

8R-HPOTrE(1-)

8R-HPOTrE(1-)

C18H29O4- (309.2066)


   

10R-HPOTrE(1-)

10R-HPOTrE(1-)

C18H29O4- (309.2066)


   

ketomycolate type-3 (XIII)

ketomycolate type-3 (XIII)

C18H29O4- (309.2066)


   

5-oxo-18-hydroxy-(6E,8Z)-octadecadienoate

5-oxo-18-hydroxy-(6E,8Z)-octadecadienoate

C18H29O4- (309.2066)


   

12,13-epoxy-(10R)-hydroxy-(8E,15Z)-octadecadienoate

12,13-epoxy-(10R)-hydroxy-(8E,15Z)-octadecadienoate

C18H29O4- (309.2066)


   

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]propanamide

N-[(4E,8E,12E)-1,3-dihydroxypentadeca-4,8,12-trien-2-yl]propanamide

C18H31NO3 (309.2304)


   

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]butanamide

N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]butanamide

C18H31NO3 (309.2304)


   

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]acetamide

N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]acetamide

C18H31NO3 (309.2304)


   

(9Z,12Z)-N-(2-hydroxyethyl)heptadeca-9,12-dienamide

(9Z,12Z)-N-(2-hydroxyethyl)heptadeca-9,12-dienamide

C19H35NO2 (309.2668)


   

2-(3-Hydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

2-(3-Hydroxybutoxy)-N-(2-(diethylamino)ethyl)-3-pyridinecarboxamide

C16H27N3O3 (309.2052)


   

dicyclomine

dicyclomine

C19H35NO2 (309.2668)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Difenidol

DIPHENIDOL

C21H27NO (309.2093)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

(9Me,4E,8E,10E-d19:3)sphingosine

(9Me,4E,8E,10E-d19:3)sphingosine

C19H35NO2 (309.2668)


   

icosenoate

icosenoate

C20H37O2 (309.2793)


A long-chain monounsaturated fatty acid anion that is the conjugate base of icosenoic acid, formed by deprotonation of the carboxylic acid group. Major species at pH 7.3.

   

(9Me,4E,8E,10E-d19:3) Sphingosine

(9Me,4E,8E,10E-d19:3) Sphingosine

C19H35NO2 (309.2668)


   

(13e)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

(13e)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

[C20H25N2O]+ (309.1967)


   

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

(1r,3ar,4s,6r)-1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

C21H27NO (309.2093)


   

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethylquinolin-4-one

2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-1,3-dimethylquinolin-4-one

C21H27NO (309.2093)


   

(13s,15s,16z)-16-ethylidene-6-methoxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

(13s,15s,16z)-16-ethylidene-6-methoxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

[C20H25N2O]+ (309.1967)


   

(13s,16ar)-13-[(1s)-1-hydroxypropyl]-1h,4h,5h,6h,7h,8h,9h,10h,11h,13h,16h,16ah-pyrido[2,1-d]1,5,9-triazacyclotridecan-2-ol

(13s,16ar)-13-[(1s)-1-hydroxypropyl]-1h,4h,5h,6h,7h,8h,9h,10h,11h,13h,16h,16ah-pyrido[2,1-d]1,5,9-triazacyclotridecan-2-ol

C17H31N3O2 (309.2416)


   

1-[(3ar,4r,5r,7as)-5-[(4e)-5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5r,7as)-5-[(4e)-5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.2093)


   

1-{5-[5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl}ethanone

1-{5-[5-(pyridin-2-yl)pent-4-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl}ethanone

C21H27NO (309.2093)


   

(6s)-6-amino-8-(4-aminocyclohexa-2,5-dien-1-yl)-7-methyl-6-(methylamino)-5-oxooctanoic acid

(6s)-6-amino-8-(4-aminocyclohexa-2,5-dien-1-yl)-7-methyl-6-(methylamino)-5-oxooctanoic acid

C16H27N3O3 (309.2052)


   

1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

1,4,7-trimethyl-6-(2-methylprop-1-en-1-yl)-1h,2h,3h,3ah,4h,5h,6h-phenaleno[2,1-d][1,3]oxazole

C21H27NO (309.2093)


   

(1r,13s,15s,16e)-16-ethylidene-6-methoxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

(1r,13s,15s,16e)-16-ethylidene-6-methoxy-1λ⁵,11-diazapentacyclo[13.2.2.0¹,¹³.0⁴,¹².0⁵,¹⁰]nonadeca-4(12),5,7,9-tetraen-1-ylium

[C20H25N2O]+ (309.1967)


   

12-(5-hydroxy-6-methylpyridin-2-yl)dodecane-1,6-diol

12-(5-hydroxy-6-methylpyridin-2-yl)dodecane-1,6-diol

C18H31NO3 (309.2304)


   

1-[(3ar,4r,5s,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5s,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.2093)


   

(1s,12s,13s,14r,15e,17r)-15-ethylidene-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

(1s,12s,13s,14r,15e,17r)-15-ethylidene-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

[C20H25N2O]+ (309.1967)


   

n-[3-({4-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]butyl}amino)propyl]-2-methylbut-2-enimidic acid

n-[3-({4-[(1-hydroxy-2-methylbut-2-en-1-ylidene)amino]butyl}amino)propyl]-2-methylbut-2-enimidic acid

C17H31N3O2 (309.2416)


   

1-[(3ar,4r,5r,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

1-[(3ar,4r,5r,7as)-5-[(3e)-5-(pyridin-2-yl)pent-3-en-1-yl]-2,3,3a,4,5,7a-hexahydro-1h-inden-4-yl]ethanone

C21H27NO (309.2093)


   

13-(1-hydroxypropyl)-1h,4h,5h,6h,7h,8h,9h,10h,11h,13h,16h,16ah-pyrido[2,1-d]1,5,9-triazacyclotridecan-2-ol

13-(1-hydroxypropyl)-1h,4h,5h,6h,7h,8h,9h,10h,11h,13h,16h,16ah-pyrido[2,1-d]1,5,9-triazacyclotridecan-2-ol

C17H31N3O2 (309.2416)


   

2-(3,7-dimethylocta-2,6-dien-1-yl)-1,3-dimethylquinolin-4-one

2-(3,7-dimethylocta-2,6-dien-1-yl)-1,3-dimethylquinolin-4-one

C21H27NO (309.2093)


   

(2e,4e)-n-(2-hydroxy-2-methylpropyl)-8-oxotetradeca-2,4-dienimidic acid

(2e,4e)-n-(2-hydroxy-2-methylpropyl)-8-oxotetradeca-2,4-dienimidic acid

C18H31NO3 (309.2304)


   

(7z)-n-[(3s)-2-oxooxolan-3-yl]tetradec-7-enimidic acid

(7z)-n-[(3s)-2-oxooxolan-3-yl]tetradec-7-enimidic acid

C18H31NO3 (309.2304)


   

n-(2-hydroxy-2-methylpropyl)-8-oxotetradeca-2,4-dienimidic acid

n-(2-hydroxy-2-methylpropyl)-8-oxotetradeca-2,4-dienimidic acid

C18H31NO3 (309.2304)


   

(1s,12s,17r)-15-ethylidene-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

(1s,12s,17r)-15-ethylidene-13-(hydroxymethyl)-17-methyl-3,17-diazapentacyclo[12.3.1.0²,¹⁰.0⁴,⁹.0¹²,¹⁷]octadeca-2(10),4,6,8-tetraen-17-ium

[C20H25N2O]+ (309.1967)


   

12-(5-hydroxy-6-methylpyridin-2-yl)dodecane-1,5-diol

12-(5-hydroxy-6-methylpyridin-2-yl)dodecane-1,5-diol

C18H31NO3 (309.2304)


   

(13e,18r)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

(13e,18r)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

[C20H25N2O]+ (309.1967)


   

(2e)-n-{3-[(4-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}butyl)amino]propyl}-2-methylbut-2-enimidic acid

(2e)-n-{3-[(4-{[(2e)-1-hydroxy-2-methylbut-2-en-1-ylidene]amino}butyl)amino]propyl}-2-methylbut-2-enimidic acid

C17H31N3O2 (309.2416)


   

(11r,13z,14r,16r,18s)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

(11r,13z,14r,16r,18s)-13-ethylidene-18-(hydroxymethyl)-11-methyl-1,11-diazapentacyclo[12.3.1.0²,⁷.0⁸,¹⁷.0¹¹,¹⁶]octadeca-2,4,6,8(17)-tetraen-11-ium

[C20H25N2O]+ (309.1967)